XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Net sales:      
Total net sales $ 23,044,796 $ 21,595,199 $ 17,572,589
Cost of sales:      
Total cost of sales 10,263,166 9,793,224 7,676,119
Gross profit 12,781,630 11,801,975 9,896,470
Operating expenses:      
Research and development 2,622,919 2,955,976 2,489,806
Selling, general and administrative 6,257,732 6,100,545 5,877,920
Total operating expenses 8,880,651 9,056,521 8,367,726
Operating income 3,900,979 2,745,454 1,528,744
Interest income 1,234 154,950 249,620
Other income 74,906 60,497 73,737
Income before income taxes 3,977,119 2,960,901 1,852,101
Income tax (benefit) expense (1,087,783) (308,882) 1,805
Net income $ 5,064,902 $ 3,269,783 $ 1,850,296
Net income per common share:      
Basic (in dollars per share) $ 0.29 $ 0.19 $ 0.11
Diluted (in dollars per share) $ 0.29 $ 0.19 $ 0.11
Weighted average shares outstanding:      
Basic (in shares) 17,225,423 16,939,302 16,867,550
Diluted (in shares) 17,226,620 17,114,191 16,942,447
Product      
Net sales:      
Total net sales $ 22,760,083 $ 20,806,121 $ 16,165,333
Cost of sales:      
Total cost of sales 10,185,510 9,568,553 7,038,717
Engineering development contracts      
Net sales:      
Total net sales 284,713 789,078 1,407,256
Cost of sales:      
Total cost of sales $ 77,656 $ 224,671 $ 637,402